학술논문

Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial
Document Type
Article
Source
In: The Lancet Rheumatology. (The Lancet Rheumatology, June 2023, 5(6):e341-e350)
Subject
Language
English
ISSN
26659913